Allergy最新文献

筛选
英文 中文
Polymeric α-Hairpinin Allergens Induce a Functional Response via a Single Antibody. 聚合α-发夹蛋白过敏原通过单一抗体诱导功能性反应。
IF 11.3 1区 医学
Allergy Pub Date : 2026-10-01 Epub Date: 2025-12-31 DOI: 10.1111/all.70201
Gage O Leighton, Taylor M Cosey, Emmanuel R De Diavoukana, Isabelle R Lytle, Alexander C Y Foo, Lars C Pedersen, Scott A Gabel, Robert M Petrovich, Min Shi, Venu Aruva, Paige Creeks, Joyce J W Wong, Jian Zhang, R Stokes Peebles, Derek Croote, Scott A Smith, Geoffrey A Mueller
{"title":"Polymeric α-Hairpinin Allergens Induce a Functional Response via a Single Antibody.","authors":"Gage O Leighton, Taylor M Cosey, Emmanuel R De Diavoukana, Isabelle R Lytle, Alexander C Y Foo, Lars C Pedersen, Scott A Gabel, Robert M Petrovich, Min Shi, Venu Aruva, Paige Creeks, Joyce J W Wong, Jian Zhang, R Stokes Peebles, Derek Croote, Scott A Smith, Geoffrey A Mueller","doi":"10.1111/all.70201","DOIUrl":"10.1111/all.70201","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":" ","pages":"3725-3727"},"PeriodicalIF":11.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12758636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to "Pilot Study Measuring Transepidermal Water Loss (TEWL) in Children Suggests Trilipid Cream Is More Effective Than a Paraffin-Based Emollient". 对“测量儿童经皮失水(TEWL)的初步研究表明三脂乳膏比石蜡基润肤剂更有效”的更正。
IF 11.3 1区 医学
Allergy Pub Date : 2026-10-01 Epub Date: 2026-05-14 DOI: 10.1111/all.70319
{"title":"Correction to \"Pilot Study Measuring Transepidermal Water Loss (TEWL) in Children Suggests Trilipid Cream Is More Effective Than a Paraffin-Based Emollient\".","authors":"","doi":"10.1111/all.70319","DOIUrl":"10.1111/all.70319","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":" ","pages":"3766"},"PeriodicalIF":11.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147939492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tezepelumab Reverses TSLP-Driven Immunometabolic Rewiring in Human cDC2s Underlying Pathogenic Th2 and Dysfunctional Treg Responses. Tezepelumab逆转tslp驱动的人类cDC2s的免疫代谢重组,其潜在的致病性Th2和功能失调的Treg反应。
IF 11.3 1区 医学
Allergy Pub Date : 2026-10-01 Epub Date: 2026-07-31 DOI: 10.1111/all.70470
Leticia Martín-Cruz, Andrés de la Rocha-Muñoz, Isabel María Peñalver-Fernández, Ángel Maldonado, Sofía Sirvent, Oscar Palomares
{"title":"Tezepelumab Reverses TSLP-Driven Immunometabolic Rewiring in Human cDC2s Underlying Pathogenic Th2 and Dysfunctional Treg Responses.","authors":"Leticia Martín-Cruz, Andrés de la Rocha-Muñoz, Isabel María Peñalver-Fernández, Ángel Maldonado, Sofía Sirvent, Oscar Palomares","doi":"10.1111/all.70470","DOIUrl":"10.1111/all.70470","url":null,"abstract":"<p><strong>Background: </strong>Thymic stromal lymphopoietin (TSLP) is a key epithelial alarmin involved in the initiation and maintenance of type 2 inflammatory airway diseases. Although tezepelumab, the first approved anti-TSLP monoclonal antibody, has shown robust clinical efficacy in asthma and CRSwNP, the molecular mechanisms underlying its mode of action remain incompletely defined.</p><p><strong>Objective: </strong>To determine whether TSLP induces a pathogenic immunometabolic program in human type 2 conventional dendritic cells (cDC2s) and whether tezepelumab can directly reverse this process.</p><p><strong>Methods: </strong>Purified human circulating cDC2s from healthy non-atopic donors were stimulated with TSLP in the presence or absence of tezepelumab. cDC2 phenotype, function, metabolism, and T-cell polarization capacity were assessed. Pathogenic Th2 responses, Treg generation, suppressive function, and metabolic fitness were analyzed.</p><p><strong>Results: </strong>TSLP induced a metabolic rewiring in human cDC2s characterized by increased glycolysis and mitochondrial oxidative phosphorylation. This metabolic hyperactivation was associated with the acquisition of a pro-type 2 phenotype and required for the induction of pathogenic T-cell responses. TSLP-activated cDC2s generated pathogenic Th2 cells and FOXP3<sup>+</sup> Tregs with impaired suppressive function and an altered metabolic profile. Tezepelumab effectively reversed TSLP-induced metabolic and functional reprogramming in cDC2s, thereby limiting pathogenic Th2 polarization while restoring the functional and metabolic properties of induced Tregs.</p><p><strong>Conclusions: </strong>We identify immunometabolic rewiring as a key mechanism of the TSLP-cDC2 axis and provide mechanistic insight into how tezepelumab reshapes pathogenic adaptive immune responses. These results support upstream epithelial alarmin blockade as a strategy to interfere with early disease-driving immune programs in type 2 inflammatory airway diseases.</p>","PeriodicalId":122,"journal":{"name":"Allergy","volume":" ","pages":"3695-3706"},"PeriodicalIF":11.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148648029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Cysteinyl Leukotrienes in Food Allergy and Anaphylaxis: A Potential Therapeutic Target. 半胱氨酸白三烯在食物过敏和过敏反应中的作用:一个潜在的治疗靶点。
IF 11.3 1区 医学
Allergy Pub Date : 2026-10-01 Epub Date: 2026-05-15 DOI: 10.1111/all.70393
Adrienn Weingärtner, Thomas Eiwegger
{"title":"Role of Cysteinyl Leukotrienes in Food Allergy and Anaphylaxis: A Potential Therapeutic Target.","authors":"Adrienn Weingärtner, Thomas Eiwegger","doi":"10.1111/all.70393","DOIUrl":"10.1111/all.70393","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":" ","pages":"3763-3765"},"PeriodicalIF":11.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13646847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147947109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-Year Post-Treatment Outcomes Following Cessation of Peanut Oral Immunotherapy: Comparisons by Clinical Allergy Status and Treatment Group. 停止花生口服免疫治疗后三年的治疗结果:临床过敏状况和治疗组的比较
IF 11.3 1区 医学
Allergy Pub Date : 2026-10-01 Epub Date: 2026-07-21 DOI: 10.1111/all.70400
Paxton Loke, Xiaofang Wang, Sophie Rosser, Melanie Lloyd, Sarah E Ashley, Adriana C Lozinsky, Julie Burns, Patrick Quinn, Michael D O'Sullivan, Michael Gold, Francesca Orsini, Mimi L K Tang
{"title":"Three-Year Post-Treatment Outcomes Following Cessation of Peanut Oral Immunotherapy: Comparisons by Clinical Allergy Status and Treatment Group.","authors":"Paxton Loke, Xiaofang Wang, Sophie Rosser, Melanie Lloyd, Sarah E Ashley, Adriana C Lozinsky, Julie Burns, Patrick Quinn, Michael D O'Sullivan, Michael Gold, Francesca Orsini, Mimi L K Tang","doi":"10.1111/all.70400","DOIUrl":"10.1111/all.70400","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":" ","pages":"3746-3751"},"PeriodicalIF":11.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13646850/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148547122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Abatacept Versus Placebo During Peanut Oral Immunotherapy for Adults With Severe Peanut Allergy 阿巴他普与安慰剂在花生口服免疫治疗成人严重花生过敏中的疗效和安全性
IF 12.4 1区 医学
Allergy Pub Date : 2026-10-01 DOI: 10.1111/all.70531
Marie‐Lee Simard, Camille Braun, Éloise Antony, Émilie Roy, Marie‐Ève Gingras, François Graham, Anne Des Roches, Louis Paradis, Kathryn Samaan, Florence Gingras‐Lessard, Roxane Labrosse, Thomas Eiwegger, Philippe Bégin
{"title":"Efficacy and Safety of Abatacept Versus Placebo During Peanut Oral Immunotherapy for Adults With Severe Peanut Allergy","authors":"Marie‐Lee Simard, Camille Braun, Éloise Antony, Émilie Roy, Marie‐Ève Gingras, François Graham, Anne Des Roches, Louis Paradis, Kathryn Samaan, Florence Gingras‐Lessard, Roxane Labrosse, Thomas Eiwegger, Philippe Bégin","doi":"10.1111/all.70531","DOIUrl":"https://doi.org/10.1111/all.70531","url":null,"abstract":"Background Unmet needs remain for disease‐modifying interventions for the treatment of severe persistent food allergies. In mice models, abatacept, a cytotoxic T lymphocyte‐associated antigen‐4 (CTLA‐4) immunoglobulin fusion protein, promotes immune tolerance to food proteins, and suppresses the initial allergen‐related induction of specific immunoglobulin E (IgE) when used as an adjuvant to allergen immunotherapy. Methods In this Phase 2a placebo‐controlled clinical trial, 14 peanut‐allergic participants (14–50 years old) with specific IgE &gt; 50 kU/L were randomized 1:1 to adjuvant abatacept vs. placebo to peanut oral immunotherapy (OIT) for 24 weeks, followed by 12 weeks of OIT alone. With the hypothesis that abatacept suppresses the transient OIT‐induced increase in specific IgE, the primary outcome was the relative change from baseline of the peanut‐specific/total IgE ratio at 24 weeks. Sustained unresponsiveness was assessed as a secondary outcome with repeated oral food challenges (OFCs) following incremental periods of peanut avoidance. Results No significant difference in the relative change in peanut‐specific/total IgE ratio from baseline was observed between groups (placebo group 87.9% vs. abatacept group 48.2%, <jats:italic>p</jats:italic> ‐value 0.26). Median minimal reactive doses on repeated OFCs were similar in both groups (3000 mg) after 4 weeks of peanut avoidance. Lower adverse event rates including anaphylaxis were observed in the abatacept group (5.9 vs. 10 per participant, <jats:italic>p</jats:italic> ‐value 0.006). Conclusion Compared to placebo, abatacept did not suppress the allergen‐related induction of peanut‐specific IgE relative to their total at 24 weeks, but improved OIT tolerability in this severely allergic adult population. Independently of abatacept, most participants achieved sustained unresponsiveness with OIT.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"272 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149083796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal Body Mass Index, Offspring Impaired Skin Barrier Function, Allergic Sensitization, and Bronchial Obstruction. 母亲体重指数,后代皮肤屏障功能受损,过敏致敏和支气管阻塞。
IF 11.3 1区 医学
Allergy Pub Date : 2026-10-01 Epub Date: 2026-06-15 DOI: 10.1111/all.70408
Eva Maria Rehbinder, Riyas Vettukattil, Corina Silvia Rueegg, Karin C Lødrup Carlsen, Christophe von Garnier, Berit Granum, Guttorm Haugen, Gunilla Hedlin, Christine Monceyron Jonassen, Björn Nordlund, Håvard O Skjerven, Knut Rudi, Anne Cathrine Staff, Cilla Söderhäll, Niki Ubags
{"title":"Maternal Body Mass Index, Offspring Impaired Skin Barrier Function, Allergic Sensitization, and Bronchial Obstruction.","authors":"Eva Maria Rehbinder, Riyas Vettukattil, Corina Silvia Rueegg, Karin C Lødrup Carlsen, Christophe von Garnier, Berit Granum, Guttorm Haugen, Gunilla Hedlin, Christine Monceyron Jonassen, Björn Nordlund, Håvard O Skjerven, Knut Rudi, Anne Cathrine Staff, Cilla Söderhäll, Niki Ubags","doi":"10.1111/all.70408","DOIUrl":"10.1111/all.70408","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":" ","pages":"3756-3759"},"PeriodicalIF":11.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148256655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-World Efficacy of Dupilumab in Chinese Atopic Dermatitis Patients and Development of a Prediction Model. 杜匹单抗在中国特应性皮炎患者中的实际疗效及预测模型的建立。
IF 11.3 1区 医学
Allergy Pub Date : 2026-10-01 Epub Date: 2026-06-09 DOI: 10.1111/all.70405
Ruojun Wang, Bang Zheng, Jiahui Zhao, Shaomin Zhong, Zhihao Jiang, Yang Liu, Hang Li, Yang Wang
{"title":"Real-World Efficacy of Dupilumab in Chinese Atopic Dermatitis Patients and Development of a Prediction Model.","authors":"Ruojun Wang, Bang Zheng, Jiahui Zhao, Shaomin Zhong, Zhihao Jiang, Yang Liu, Hang Li, Yang Wang","doi":"10.1111/all.70405","DOIUrl":"10.1111/all.70405","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":" ","pages":"3752-3755"},"PeriodicalIF":11.3,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148209523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to article: Structural Basis for Trivalent Cross-Linking of a Patient-Derived IgE Antibody by the Major Peanut Allergen Ara h 2.0201. 对文章的更正:主要花生过敏原Ara h 2.0201患者源性IgE抗体三价交联的结构基础。
IF 11.3 1区 医学
Allergy Pub Date : 2026-09-28 DOI: 10.1111/all.70529
{"title":"Correction to article: Structural Basis for Trivalent Cross-Linking of a Patient-Derived IgE Antibody by the Major Peanut Allergen Ara h 2.0201.","authors":"","doi":"10.1111/all.70529","DOIUrl":"https://doi.org/10.1111/all.70529","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":" ","pages":""},"PeriodicalIF":11.3,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149068847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-Sensitization, Reactivity and Severity: Three Distinct Layers of Vicilin-Based Diagnosis. 共同致敏,反应性和严重性:基于维西林的诊断的三个不同层次。
IF 11.3 1区 医学
Allergy Pub Date : 2026-09-27 DOI: 10.1111/all.70527
Bülent Enis Şekerel, Özge Soyer, Melike Ocak
{"title":"Co-Sensitization, Reactivity and Severity: Three Distinct Layers of Vicilin-Based Diagnosis.","authors":"Bülent Enis Şekerel, Özge Soyer, Melike Ocak","doi":"10.1111/all.70527","DOIUrl":"https://doi.org/10.1111/all.70527","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":" ","pages":""},"PeriodicalIF":11.3,"publicationDate":"2026-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149068899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书